Publications

5808 Results

Low incidence of pneumonitis on SWOG 0023: a preliminary analysis of an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib/placebo maintenance in patients with inoperable stage III non-small cell lung cancer

Authors
K Kelly;LE Gaspar;K Chansky;KS Albain;J Crowley;DR Gandara
Journal / Conference
Proc of the ASCO, JCO 23(16S):634s (#7058)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0023

SWOG/Intergroup 9623: a phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (ACHPCS) for primary breast cancer in women with >4 involved axillary lymph nodes.

Authors
SI Bearman;SJ Green;J Gralow;W Barlow;C Hudis;A Wolff;J Ingle;G Hortobagyi;R Livingston;S Martino
Journal / Conference
Proc of the ASCO, JCO 23(16S):21s (#572)
Year
2005
Research Committee(s)
Breast
Study Number(s)
S9623

Optimal combined modality treatment improves outcome of locally advanced bladder cancer: analyis of SWOG 8710

Authors
ZA Dotan;DF Bajorin;BH Grossman;HW Herr
Journal / Conference
Proc of the ASCO, JCO 23(16S):385s (#4531)
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Dose-dense (DD)AC followed by paclitaxel is associated with moderate frequent anemia compared to sequential (S) and/or less DD Treatment: update by CALGB on breast cancer intergroup trial C9741 with ECOG, SWOG, & NCCTG

Authors
ML Citron;DA Berry;C Cirrincione;RB Livingston;W Gradishar;E Perez;H Muss;L Norton;E Winer;C Hudis
Journal / Conference
Proc of the ASCO, JCO 23(16S):33s (#620)
Year
2005
Research Committee(s)
Breast
Study Number(s)
C9741

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17

Authors
PE Goss;JN Ingle;S Martino;NJ Robert;HB Muss;MJ Piccart;M Castiglione;D Tu;LE Shepherd;KI Pritchard;RB Livingston;NE Davidson;L Norton;EA Perez;JS Abrams;DA Cameron;MJ Palmer;JL Pater
Journal / Conference
Journal of the National Cancer Institute 97(17):1262-1271
Year
2005
Research Committee(s)
Breast
Study Number(s)
JMA17

Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM

Authors
M Quezado;R Ronchetti;A Rapkiewicz;M Santi;D Blumenthal;EJ Rushing
Journal / Conference
Clinical Neuropathology 24(4):163-169
Year
2005
Research Committee(s)
Brain
Study Number(s)
S0001

Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: safety results from the US Intergroup phase II trial ACOSOG Z9000

Authors
RP Dematteo;CR Antonescu;V Chadaram;YN You;L McCall;R Maki;A Murgo;G Demetri;P Pisters;MF Brennan
Journal / Conference
Proc of the ASCO, JCO 23(16S):818s (#9009)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
CTSU/Z9000

Operating characteristics of prostate-specific antigen in men with an initial psa level of 3.0 ng/mL or lower

Authors
IM Thompson;DP Ankerst;C Chi;MS Lucia;PJ Goodman;JJ Crowley;HL Parnes;CA Coltman
Journal / Conference
The Journal of the American Medical Association 294(1):66-70
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

CTFG (CCN2) predicts OS and DFS in adult acute lymphoblastic leukemia

Authors
O Sala-Torra;H Gundacker;DL Stirewalt;PA Ladne;EL Pogosova-Agadjanyan;ML Slovak;CL Willman;S Heimfeld;DH Boldt;JP Radich
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #336
Year
2005
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9400

An update of a phase II trial of CHOP followed by tositumomab/iodine I-131 tositumomab (Bexxar) for front-line treatment of advanced stage, follicular lymphoma: Southwest Oncology Group Protocol 9911

Authors
OW Press;J Unger;D Maloney;RM Braziel;M LeBlanc;T Grogan;TP Miller;RI Fisher
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #352
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
S9911